What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Transforming growth factor beta, Transforming growth factor, Molecular biology, Internal medicine and Cancer research.
David Danielpour has included themes like Antibody and Autocrine signalling in his Transforming growth factor beta study.
As a part of the same scientific family, he mostly works in the field of Transforming growth factor, focusing on Cell culture and, on occasion, Platelet-derived growth factor and Platelet-derived growth factor receptor.
His research in Molecular biology intersects with topics in Receptor, SMAD, Immunoprecipitation and TGF beta 1.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology.
His biological study spans a wide range of topics, including Protein kinase B, Phosphorylation, Tumor microenvironment, Metastasis and Cytotoxic T cell.
His most cited work include:
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture (432 citations)
- Mesoderm induction in amphibians: the role of TGF-beta 2-like factors (374 citations)
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt (326 citations)
What are the main themes of his work throughout his whole career to date?
David Danielpour mostly deals with Cancer research, Transforming growth factor, Molecular biology, Transforming growth factor beta and Cell biology.
His Cancer research study incorporates themes from Cancer, Prostate cancer, Tumor progression, Survivin and PI3K/AKT/mTOR pathway.
David Danielpour interconnects Cell culture, Receptor and Cell growth in the investigation of issues within Transforming growth factor.
While the research belongs to areas of Molecular biology, David Danielpour spends his time largely on the problem of Gene expression, intersecting his research to questions surrounding Messenger RNA.
Within one scientific family, David Danielpour focuses on topics pertaining to Autocrine signalling under Transforming growth factor beta, and may sometimes address concerns connected to Paracrine signalling.
His work focuses on many connections between Cell biology and other disciplines, such as Apoptosis, that overlap with his field of interest in Downregulation and upregulation.
He most often published in these fields:
- Cancer research (40.77%)
- Transforming growth factor (34.62%)
- Molecular biology (33.08%)
What were the highlights of his more recent work (between 2012-2020)?
- Cancer research (40.77%)
- Survivin (8.46%)
- mTORC1 (9.23%)
In recent papers he was focusing on the following fields of study:
David Danielpour mainly investigates Cancer research, Survivin, mTORC1, Autocrine signalling and Prostate cancer.
His Cancer research research includes elements of Cell growth, Transcriptome, LNCaP, Tumor progression and Androgen receptor.
His research investigates the connection between Tumor progression and topics such as Transforming growth factor beta that intersect with issues in DEPTOR, Metastasis and Epithelial–mesenchymal transition.
The various areas that David Danielpour examines in his Survivin study include Inhibitor of apoptosis, Small hairpin RNA, Cell biology, Gene silencing and Cyclin.
His Molecular biology research incorporates themes from Cancer cell and Apoptosis.
His Gene expression profiling research is multidisciplinary, incorporating elements of Transforming growth factor, Internal medicine and microRNA.
Between 2012 and 2020, his most popular works were:
- TGF-β upregulates miR-181a expression to promote breast cancer metastasis (200 citations)
- Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. (28 citations)
- Critical Role of a Survivin/TGF-β/mTORC1 Axis in IGF-I-Mediated Growth of Prostate Epithelial Cells (27 citations)
In his most recent research, the most cited papers focused on:
David Danielpour mainly focuses on Cancer research, Mitochondrion, Epithelial–mesenchymal transition, Metastasis and LNCaP.
His work deals with themes such as Tumor progression, PI3K/AKT/mTOR pathway, Autocrine signalling and Survivin, which intersect with Cancer research.
His Survivin study integrates concerns from other disciplines, such as Inhibitor of apoptosis, Small hairpin RNA, Signal transduction, Cell biology and Gene silencing.
His research integrates issues of Glycolysis, Molecular biology and Stem cell in his study of Mitochondrion.
David Danielpour undertakes multidisciplinary studies into Molecular biology and Pyruvate dehydrogenase kinase in his work.
The study incorporates disciplines such as Transforming growth factor beta, DEPTOR and PCA3 in addition to Epithelial–mesenchymal transition.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
